GASTROINTESTINAL STROMAL TUMORS
Clinical trials for GASTROINTESTINAL STROMAL TUMORS explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL STROMAL TUMORS trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL STROMAL TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat stomach cancer: paclitaxel shows promise in select patients
Disease control CompletedThis study tested the chemotherapy drug paclitaxel in 40 adults with advanced gastrointestinal stromal tumor (GIST) that had stopped responding to three standard treatments. The goal was to see if paclitaxel could control the disease in patients whose tumors have low levels of a …
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated May 17, 2026 03:15 UTC
-
New drug shows promise in controlling rare stomach cancer
Disease control CompletedThis study tested the drug nilotinib in 34 adults with advanced GIST that could not be removed by surgery. The goal was to see if the drug could shrink or stop the growth of tumors. While not a cure, the treatment helped control the disease in some patients, offering a potential …
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New drug shows promise for rare stomach cancer in chinese patients
Disease control CompletedThis study tested the safety and effectiveness of avapritinib in 61 Chinese patients with a rare stomach cancer called GIST. Researchers monitored side effects and dose adjustments in real-world settings. The goal was to see how well the drug works outside of strict clinical tria…
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Sponsor: CStone Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New combo therapy shows promise for Tough-to-Treat GIST
Disease control CompletedThis study tested a combination of two drugs, avelumab and axitinib, in 58 adults with advanced gastrointestinal stromal tumors (GIST) that had stopped responding to standard treatments. The goal was to see if the combination could keep the cancer from growing for at least 3 mont…
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Phase: PHASE2 • Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
AI reads scans and biopsies to spot dangerous stomach tumors before surgery
Diagnosis CompletedThis study tested an artificial intelligence (AI) model that combines CT scans, pathology images, and patient data to diagnose gastrointestinal stromal tumors (GISTs), predict their risk level, and identify genetic mutations. Researchers enrolled 300 adults with suspected stomach…
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Sponsor: Qun Zhao • Aim: Diagnosis
Last updated May 05, 2026 11:54 UTC